Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Nutriband Inc WT (NQ: NTRBW ) 1.500 UNCHANGED Streaming Delayed Price Updated: 3:43 PM EST, Nov 13, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 1.500 Bid (Size) 1.500 (5) Ask (Size) 2.000 (17) Prev. Close 1.500 Today's Range 1.500 - 1.500 52wk Range 0.1885 - 3.440 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application October 31, 2024 Via ACCESSWIRE Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica October 17, 2024 Via ACCESSWIRE Performance YTD +400.17% +400.17% 1 Month -23.47% -23.47% 3 Month +57.89% +57.89% 6 Month +38.89% +38.89% 1 Year +206.12% +206.12% More News Read More Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17 October 02, 2024 Via ACCESSWIRE As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse September 24, 2024 Via FinancialNewsMedia Exposures Product Safety Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors May 16, 2024 Via ACCESSWIRE Nutriband Inc. Announces $8.4M Private Placement April 19, 2024 Via ACCESSWIRE Nutriband Inc. to Present at The Microcap Conference Atlantic City January 30th through February 1st January 29, 2024 Via ACCESSWIRE As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse September 24, 2024 From FN Media Group LLC Via GlobeNewswire NUTRIBAND RECEIVES CHINA PATENT NOTICE OF ALLOWANCE FOR ITS AVERSA™ ABUSE DETERRENT TRANSDERMAL TECHNOLOGY September 24, 2024 Via FinancialNewsMedia Topics Intellectual Property Exposures Intellectual Property Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology September 24, 2024 Via ACCESSWIRE Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch September 20, 2024 Via ACCESSWIRE Nutriband Inc. Authorizes $1M Share Buyback Program September 16, 2024 Via ACCESSWIRE Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025 September 04, 2024 Via ACCESSWIRE Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25 July 19, 2024 Via ACCESSWIRE Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology July 15, 2024 Via ACCESSWIRE Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl June 20, 2024 Via ACCESSWIRE Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year June 03, 2024 Via ACCESSWIRE Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA Submission April 24, 2024 Via ACCESSWIRE Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group April 23, 2024 Via ACCESSWIRE Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance April 01, 2024 Via ACCESSWIRE Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch March 27, 2024 Via ACCESSWIRE Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting March 25, 2024 Via ACCESSWIRE Prescription Transdermal Patch Abuse and Accidental Pediatric Exposure Remains a Serious Problem in the United States - Surveillance Data to Be Presented at 2024 American Academy of Pain Medicine Annual Meeting March 04, 2024 Via ACCESSWIRE Nutriband CEO Publishes Letter to Shareholders January 26, 2024 Via ACCESSWIRE Nutriband Signs Commercial Development and Clinical Supply Agreement With Kindeva Drug Delivery for Aversa(TM) Fentanyl, an Abuse Deterrent Fentanyl Patch January 05, 2024 Via ACCESSWIRE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
